Patient safety is now closely linked to cyber resilience. As healthcare delivery organisations (HDOs) integrate IoT and medical devices (IoMT), they face rising risks from ransomware and legacy vulnerabilities.
A newly published clinical study evaluates omega-3 bonded to phospholipids through Naturmega’s Ruby-O® BPL-O3™ platform. Despite delivering a lower omega-3 dose than standard triglyceride fish oil, Ruby-O® helped significantly more individuals reach healthier triglyceride levels and move out of cardiovascular risk ranges, while also supporting improvements in Omega-3 Index levels.
Magnesium is often featured in popular supplement formulae for brain health, yet most forms of magnesium can’t cross the blood-brain barrier to a sufficient degree to deliver the benefits they promise.
Ready to gain an edge in the evolving healthspan market? In this e-book, we explore how joint health and mobility can open the door to differentiated solutions that help consumers stay active, mobile and independent for longer.
A new breast cancer risk assessment program is transforming care by offering same-day testing, personalized risk counseling, and earlier detection for patients in underserved communities.
As demand for outsourced pharmaceutical, biotech, and medical device production continues to surge, contract manufacturers (CMOs and CDMOs) face growing pressure to deliver speed, quality, and compliance—while staying agile in a rapidly evolving market